About this Event
Join us for the Midlands edition of the 2025 Fall Seminar Series: The GLP-1 Effect: Science, Strategy, and the Future of Workforce Wellbeing.
This luncheon features a cross-sector panel of experts exploring the evolving impact of GLP-1 medications on workforce health, chronic disease prevention, behavior change, and employee benefits strategy.
Panelists will share insights across four key dimensions:
- Clinical science and evidence, including how GLP-1s work and what the latest research shows
- Behavioral health and lifestyle change, including mental health implications and long-term motivation
- Employer strategy, from coverage decisions and culture to stigma and employee engagement
- Cost, access, and equity, including payer considerations and long-term outcomes
Attendees will enjoy a healthy, delicious lunch and an opportunity to network and connect with fellow SCHBC members, exhibitors, and sponsors—alongside a timely, expert-led panel discussion with practical takeaways for today’s workplace leaders.
This event is free to attend, but space is limited. Please RSVP to confirm your participation.
Thank you to our Fall 2025 Seminar Series Sponsor, Novo Nordisk.
As a global leader in chronic disease care, Novo Nordisk is committed to improving health and driving innovation that supports healthier communities. Their support helps us convene cross-sector leaders to share valuable insights on the future of workforce wellbeing.
Event Venue & Nearby Stays
The Palmetto Club, 1231 Sumter Street, Columbia, United States
USD 0.00
